A Four-Part Study to Assess the Safety, Tolerability, PK and PD of ONO-5788 in Healthy Adult Volunteers
Condition: Acromegaly Interventions: Drug: ONO-5788; Drug: ONO-5788 Placebo; Drug: Octreotide; Drug: Octreotide Placebo Sponsor: Ono Pharmaceutical Co. Ltd Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Acromegaly | Study